Trending Topic

Rights Approval

Automatically clustered newsroom coverage around one of the most active themes in the intellectual property ecosystem.

Moleculin Expands Annamycin Patent Rights with New Approval in South Korea
PatentsGlobal

Moleculin Expands Annamycin Patent Rights with New Approval in South Korea

Moleculin has strengthened its global intellectual property holdings by obtaining a patent allowance for Annamycin in South Korea. This development marks a significant step in the company’s efforts to protect and commercialize its innovative oncology drug worldwide.

Wednesday, November 18, 2026
Newsletters & Digests

Follow Rights Approval

Subscribe to receive daily and weekly newsroom coverage aligned to this trend cluster and adjacent IP developments.

Choose your regions
Choose your categories
By subscribing, you agree to receive IIPLA newsroom emails. You can update preferences or unsubscribe anytime.